← Leaderboards
Ke Zhang
University Of California Los Angeles
$3,637,197
Attributed
$3,837,197
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $749.9K · FY2006–16$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,837,197 · 11
By mechanism
R44$2,231,721 · 2
R21$411,950 · 1
R43$400,000 · 1
P20$302,951 · 2
R01$261,156 · 1
R29$208,538 · 1
Top collaborators
- Andrew Saxon2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Andrew Saxon$9,188,046
- Emil Reisler$8,703,797
- Otoniel Martinez-Maza$22,455,072
- Genhong Cheng$27,178,241
- Daniel Kaufman$8,790,517
Others in their field
Top investigators on “Source”
- Richard A Gibbs · Baylor College Of Medicine$285,393,445
- David Heimbrook · Leidos Biomedical Research, Inc.$233,184,481
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Jeffrey P Krischer · University Of South Florida$224,745,020
- Albert Lazzarini · California Institute Of Technology$202,317,285
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$155,571,437
Research focus
SourceBaseNext GenerationIn VitroEffective TherapyInhalant Dose FormGrantFood HypersensitivityDesignGenerationsAllergic ResponseB LymphocyteAllergic RhinitisHypersensitivityDeveloped CountriesAllergy To PeanutsAllergicComplexAnaphylaxisCrosslinkAllergic DiseaseEffector CellBasophilsFunding
Grant awards (17)
Targeting surface-bound IgE as a novel allergy therapeutic$739,653
R44 · FY2016 · AI · contact PI
Targeting surface-bound IgE as a novel allergy therapeutic$749,892
R44 · FY2015 · AI · contact PI
Targeting surface-bound IgE as a novel allergy therapeutic$200,000
R43 · FY2013 · AI · contact PI
IgE-guided RNAi silencing of FceRIb expression as a novel allergy therapeutic$180,950
R21 · FY2013 · AI · contact PI
IgE-guided RNAi silencing of FceRIb expression as a novel allergy therapeutic$231,000
R21 · FY2012 · AI · contact PI
Targeting surface-bound IgE as a novel allergy therapeutic$200,000
R43 · FY2012 · AI · contact PI
BIOINFORMATICS CORE$166,651
P20 · FY2011 · RR · contact PI
BIOINFORMATICS CORE$136,300
P20 · FY2010 · RR · contact PI
High Efficiency X-ray Fluorescence Detectors$362,271
R44 · FY2009 · RR · contact PI
High Efficiency X-ray Fluorescence Detectors$379,905
R44 · FY2008 · RR · contact PI
SEGMENTATION$2,576
P41 · FY2008 · RR · contact PI
SEGMENTATION$5,020
P41 · FY2007 · RR · contact PI
SECOND GENERATION MULTILAYER ANALYZER ARRAY DETECTOR$13,285
P41 · FY2006 · RR · contact PI
Impact of Anti-IL-4 Therapy on Immune Polarization$152,500
R01 · FY2003 · AI
Impact of Anti-IL-4 Therapy on Immune Polarization$108,656
R01 · FY2002 · AI
CHIMERIC IG MRNAS AND HUMAN ISOTYPE SWITCHING$103,817
R29 · FY2001 · AI
CHIMERIC IG MRNAS AND HUMAN ISOTYPE SWITCHING$104,721
R29 · FY2000 · AI